StockData
Relay Therapeutics, Inc. logo

Relay Therapeutics, Inc. (RLAY) stock

RLAYNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$16.47−0.80 (-4.63%)

Close on Nov 17, 2026Market cap $3.61BP/E –Yield –

Relay Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Relay Therapeutics

Relay Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Relay Therapeutics figures

See a number that looks wrong?